Primary Category:

Cancer Control and Prevention Protocols

Disease Category:

Leukemia, Myelodysplastic Syndrome


Temporarily Closed

The National Myelodysplastic Syndromes (MDS) Study



Eligible for screening study DCP 001

This protocol has additional regulatory requirements to be completed prior to registering any patients at your site.  Please contact Amber Boerner at 406-969-6067 or for additional information.

To help protect the safety and welfare of human subject participants and research staff during the COVID-19 epidemic, enrollment of new participants on NHLBI-MDS is suspended effective immediately, 03/27/20, until further notice, and all follow-up research sample collection and shipment should be discontinued.